Research progress on prognostic factors and comprehensive prevention and treatment strategies of tuberculous pericarditis

doi:10.19983/j.issn.2096-8493.20250031

Abstract

Abstract:

Tuberculous pericarditis (TBP) is a rare yet serious tuberculous heart disease, characterized by a high mortality and morbidity rate, facing challenges in diagnosis and treatment. This article reviews the epidemiology, current diagnosis and treatment status, and prognostic factors of TBP from the perspective of social-ecological system theory. It highlights the importance of multidisciplinary collaboration in facilitating early diagnosis and standardized treatment, optimizeing prevention and care delivery systems, strengthening information technology infrastructure, improveing patient support mechanisms, and prioritizing talent training and scientific research. These comprehensive prevention and control strategy recommendations offer a robust foundation for enhancing clinical management and informing policy improvements related to TBP.

Key words: Pericarditis, tuberculous, Epidemiologic factors, Universal precautions, Review literature as topic, Social-ecological systems theory

CLC Number:

R52
R542.11

Xie Xuping, Zeng Xiaogang, Li Fuping, Sun Nannan, Yu Limei, Jiang Qilong, Tang Wenshuai. Research progress on prognostic factors and comprehensive prevention and treatment strategies of tuberculous pericarditis[J]. Journal of Tuberculosis and Lung Disease , 2025, 6(4): 464-471. doi: 10.19983/j.issn.2096-8493.20250031

Figures/Tables 2

References 50

[1]	Wiysonge CS, Ntsekhe M, Thabane L, et al. Interventions for treating tuberculous pericarditis. Cochrane Database Syst Rev, 2017, 9(9):CD000526. doi:10.1002/14651858.CD000526.pub2.
[2]	Venuti L, Condemi A, Albano C, et al. Tuberculous Pericarditis in Childhood: A Case Report and a Systematic Literature Review. Pathogens, 2024, 13(2):110. doi:10.3390/pathogens13020110.
[3]	Vaezghasemi M, Vogt T, Lindkvist M, et al. Multifaceted determinants of social-emotional problems in preschool children in Sweden: an ecological systems theory approach. SSM Popul Health, 2023, 21:101345. doi:10.1016/j.ssmph.2023.101345.
[4]	余豪如, 张玲玲, 孙妞妞, 等. 社会生态系统理论在护理领域的应用进展. 全科护理, 2023, 21(36):5064-5069. doi:10.12104/j.issn.1674-4748.2023.36.005.
[5]	孙倩, 朱文娟. 社会生态系统理论视角下老年人躯体复原力研究进展. 护理研究, 2024, 38(20):3670-3674. doi:10.12102/j.issn.1009-6493.2024.20.018.
[6]	Isiguzo G, Du Bruyn E, Howlett P, et al. Diagnosis and Management of Tuberculous Pericarditis: What Is New?. Curr Cardiol Rep, 2020, 22(1):2. doi:10.1007/s11886-020-1254-1. pmid: 31940097
[7]	Howlett P, Du Bruyn E, Morrison H, et al. The immunopathogenesis of tuberculous pericarditis. Microbes Infect, 2020, 22(4-5):172-181. doi:10.1016/j.micinf.2020.02.001. pmid: 32092538
[8]	Reuter H, Burgess LJ, Doubell AF. Epidemiology of pericardial effusions at a large academic hospital in South Africa. Epidemiol Infect, 2005, 133(3):393-399. doi:10.1017/s0950268804003577. pmid: 15962545
[9]	胡鑫洋, 高静韬. 世界卫生组织《2024年全球结核病报告》解读. 结核与肺部疾病杂志, 2024, 5(6):500-504. doi:10.19983/j.issn.2096-8493.2024164.
[10]	Dybowska M, Błasińska K, Gᶏtarek J, et al. Tuberculous Pericarditis-Own Experiences and Recent Recommendations. Diagnostics (Basel), 2022, 12(3):619. doi:10.3390/diagnostics12030619.
[11]	Yadav S, Shah S, Iqbal Z, et al. Pericardiectomy for Constrictive Tuberculous Pericarditis: A Systematic Review and Meta-analysis on the Etiology, Patients’ Characteristics, and the Outcomes. Cureus, 2021, 13(9):e18252. doi:10.7759/cureus.18252.
[12]	Reddy P, Kane GC, Oh JK, et al. The Evolving Etiologic and Epidemiologic Portrait of Pericardial Disease. Can J Cardiol, 2023, 39(8):1047-1058. doi:10.1016/j.cjca.2023.05.011.
[13]	Obihara NJ, Walters E, Lawrenson J, et al. Tuberculous Pericardial Effusions in Children. J Pediatric Infect Dis Soc, 2018, 7(4):346-349. doi:10.1093/jpids/pix087. pmid: 29096017
[14]	Hugo-Hamman CT, Scher H, De Moor MM. Tuberculous pericarditis in children: a review of 44 cases. Pediatr Infect Dis J, 1994, 13(1):13-18. doi:10.1097/00006454-199401000-00004. pmid: 8170726
[15]	马玙, 朱莉贞, 潘毓萱. 结核病病. 北京: 人民卫生出版社, 2006.
[16]	王永生, 周航, 刘蔺, 等. 结核感染T细胞斑点试验在结核性心包炎诊断中的应用. 四川医学, 2013, 34(2):159-160. doi:10.16252/j.cnki.issn1004-0501-2013.02.021.
[17]	Ebrahimzadeh A, Pagheh AS, Mousavi T, et al. Serosal membrane tuberculosis in Iran: A comprehensive review of evidences. J Clin Tuberc Other Mycobact Dis, 2023, 31:100354. doi:10.1016/j.jctube.2023.100354.
[18]	Chang SA. Tuberculous and Infectious Pericarditis. Cardiol Clin, 2017, 35(4):615-622. doi:10.1016/j.ccl.2017.07.013.
[19]	Liebenberg JJ, Dold CJ, Olivier LR. A prospective investigation into the effect of colchicine on tuberculous pericarditis. Cardiovasc J Afr, 2016, 27(6):350-355. doi:10.5830/CVJA-2016-035. pmid: 27965998
[20]	Naicker K, Ntsekhe M. Tuberculous pericardial disease: a focused update on diagnosis, therapy and prevention of complications. Cardiovasc Diagn Ther, 2020, 10(2):289-295. doi:10.21037/cdt.2019.09.20.
[21]	Mayosi BM, Ntsekhe M, Bosch J, et al. Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med, 2014, 371(12):1121-1130. doi:10.1056/NEJMoa1407380.
[22]	Adler Y, Charron P, Imazio M et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J, 2015, 36(42):2921-2964. doi:10.1093/eurheartj/ehv318.
[23]	Tzani A, Doulamis IP, Tzoumas A, et al. Meta-Analysis of Population Characteristics and Outcomes of Patients Undergoing Pericardiectomy for Constrictive Pericarditis. Am J Cardiol, 2021, 146: 120-127. doi:10.1016/j.amjcard.2021.01.033. pmid: 33539860
[24]	Oruc MA, Ozdemir S, Oztomurcuk D. Characteristics of tuberculosis-related deaths and risk factors: a retrospective cohort study in Samsun province of Turkey. Postgrad Med, 2022, 134(2): 217-223. doi:10.1080/00325481.2022.2029106. pmid: 35048749
[25]	Tegegne BS, Mengesha MM, Teferra AA, et al. Association between diabetes mellitus and multi-drug-resistant tuberculosis: evidence from a systematic review and meta-analysis. Syst Rev, 2018, 7(1): 161. doi:10.1186/s13643-018-0828-0. pmid: 30322409
[26]	Steigler P, Chhiba M, Francis V, et al. T cell responses to Mycobacterium indicus pranii immunotherapy and adjunctive glucocorticoid therapy in tuberculous pericarditis. Vaccine X, 2022, 11:100177. doi:10.1016/j.jvacx.2022.100177.
[27]	Ramasamy V, Mayosi BM, Sturrock ED, et al. Established and novel pathophysiological mechanisms of pericardial injury and constrictive pericarditis. World J Cardiol, 2018, 10(9):87-96. doi:10.4330/wjc.v10.i9.87. pmid: 30344956
[28]	陈杰, 罗勇, 袁武, 等. 112例结核性缩窄性心包炎外科治疗的临床分析. 四川医学, 2024, 45(10):1057-1060. doi:10.16252/j.cnki.issn1004-0501-2024.10.001.
[29]	Busch C, Penov K, Amorim PA, et al. Risk factors for mortality after pericardiectomy for chronic constrictive pericarditis in a large single-centre cohort. Eur J Cardiothorac Surg, 2015, 48(6): e110-e116. doi:10.1093/ejcts/ezv322.
[30]	谭隽怡, 向明确, 李天驹, 等. 营养因素与结核病患者预后相关研究进展. 中国感染与化疗杂志, 2024, 24(3): 366-370. doi:10.16718/j.1009-7708.2024.03.019.
[31]	陈志, 梁建琴. 结核病重症患者营养评估及营养支持治疗专家共识. 中国防痨杂志, 2022, 44(5):421-432. doi:10.19982/j.issn.1000-6621.20220041.
[32]	丁芹, 陈薇, 张胜康, 等. 肺外结核患者的营养状况调查及影响因素分析. 中国防痨杂志, 2023, 45(9):839-844. doi:10.19982/j.issn.1000-6621.20230221.
[33]	高雅, 吴桂辉, 吴世幸, 等. 258例住院肺外结核病患者营养状况及其相关风险因素分析. 临床肺科杂志, 2023, 28(2):167-171. doi:10.3969/j.issn.1009-6663.2023.02.002.
[34]	杨红雨, 刘巧林, 康雄, 等. 结核病与AIDS共病预后影响因素及综合防治策略研究进展. 结核与肺部疾病杂志, 2024, 5(6):590-596. doi:10.19983/j.issn.2096-8493.2024109.
[35]	孙青峰, 李浩然, 逄宇, 等. 结核病与抑郁症共病的研究进展. 中国防痨杂志, 2024, 46(1):106-111. doi:10.19982/j.issn.1000-6621.20230381.
[36]	夏金红, 朱爱珍, 金婷婷, 等. 综合社会支持对老年结核病患者的生活质量影响分析. 中国防痨杂志, 2024, 46(S1):210-212.
[37]	阮淑金, 曾坚, 陈敬芳, 等. 结核病治疗依从性状况、影响因素及干预措施研究进展. 结核与肺部疾病杂志, 2023, 4(5):419-424. doi:10.19983/j.issn.2096-8493.20230076.
[38]	陈伟, 孙慧娟, 赵雁林. 新时期我国结核病防治服务体系建设及展望. 结核与肺部疾病杂志, 2024, 5(2): 95-100. doi:10.19983/j.issn.2096-8493.2024025.
[39]	刘二勇, 李玉红, 周林, 等. 统筹兼顾:肺外结核应纳入防治规划. 中国防痨杂志, 2021, 43(5): 428-431. doi:10.3969/j.issn.1000-6621.2021.05.003.
[40]	王立群, 孙国琴. 医保背景下耐药结核病经济负担的分析. 中国防痨杂志, 2024, 46(S1):313-315.
[41]	曾谊, 兰学立, 路希维. 重视结核病相关疾病的整合医学管理. 中国防痨杂志, 2024, 46(7): 735-738. doi:10.19982/j.issn.1000-6621.20240173.
[42]	梁晨, 唐神结, 林明贵. 结核病综合治疗研究进展. 结核与肺部疾病杂志, 2024, 5(1):70-80. doi:10.19983/j.issn.2096-8493.20230112.
[43]	周文雍, 文泽轩, 高梦贤, 等. 全国结核病免费医疗策略实施的效果和影响预测. 中国防痨杂志, 2023, 45(9):845-856. doi:10.19982/j.issn.1000-6621.20230143.
[44]	刘翠华, 任小波, 汪静, 等. 科技助力结核病防控:现状、进展与对策. 中国科学院院刊, 2022, 37(1):112-122. doi:10.16418/j.issn.1000-3045.20211116002.
[45]	徐彩红, 赵雁林. 构建智慧化网络助力结核病防治. 中国防痨杂志, 2022, 44(3):215-218. doi:10.19982/j.issn.1000-6621.20210724.
[46]	陈伟, 李雪, 刘小秋, 等. 《全国结核病防治规划(2024—2030年)》解读. 中国防痨杂志, 2024, 46(12):1-17. doi:10.19982/j.issn.1000-6621.20240585.
[47]	宋毅杰, 徐修远, 王宁, 等. 肺结核外科数据库系统与区域信息共享平台构建. 中国胸心血管外科临床杂志, 2023, 30(12):1749-1756. doi:10.7507/1007-4848.202307005.
[48]	王倩, 郭肖岩, 李海涛, 等. 山东省结核病防治综合管理智慧化平台构建与应用. 中国公共卫生, 2024, 40(4):516-520. doi:10.11847/zgggws1143749.
[49]	赵亚芳, 蔡青山. 人工智能技术在结核病领域应用现状. 浙江中西医结合杂志, 2024, 34(1):88-91. doi:10.3969/j.issn.1005-4561.2024.01.021.
[50]	李汶翰, 杨静, 李春华. 人工智能在肺结核影像诊断及耐药性预测中的研究进展. 中国防痨杂志, 2024, 46(9):1098-1103. doi:10.19982/j.issn.1000-6621.20240123.